查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球急性呼吸窘迫综合征设备市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测
市场调查报告书
商品编码
1305236

全球急性呼吸窘迫综合征设备市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

Global Acute Respiratory Distress Syndrome Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球急性呼吸窘迫综合征设备市场需求将从2022年的314.32百万美元达到近669.86百万美元，2023-2030年的复合年增长率为9.92%。

急性呼吸窘迫综合征（ARDS）设备是指用于为ARDS患者提供呼吸支持的医疗器械和设备。ARDS是一种严重的呼吸系统疾病，可因肺炎、败血症、创伤或吸入性损伤等各种病症而发生。其特征是肺部炎症，可导致液体积聚和呼吸困难。ARDS设备用于帮助ARDS患者更轻松有效地呼吸。ARDS设备包括机械呼吸机、体外膜肺氧合（ECMO）机和高流量鼻插管系统。ARDS设备对ARDS患者的治疗至关重要，因为这种疾病可能危及生命。这些设备有助于改善氧合，减轻肺部的工作负荷，使患者从导致ARDS的潜在疾病中恢复过来。

市场动态：

由于人口老龄化、慢性病发病率上升、败血症和肺炎发病率升高等因素，ARDS的发病率正在上升，导致对ARDS设备的需求不断增长，以便为该病患者提供呼吸支持。机械呼吸机和ECMO机等呼吸支持设备的技术进步提高了这些设备的效率和效果，推动了ARDS设备市场的增长。例如，新的通气模式，如容量控制通气和压力控制通气，可提供更精确的呼吸支持控制。全球老年人口不断增长，导致对ARDS设备的需求增加，因为老年人更容易患ARDS等呼吸系统疾病。此外，老年人群通常还患有其他合并症，可能需要使用ARDS设备。世界各国政府正在投资于医学研究、临床试验和旨在改善ARDS患者预后的倡议。COVID-19大流行导致ARDS设备需求激增，特别是机械呼吸机，因为COVID-19严重病例可导致ARDS。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构，并评估全球范围内的竞争吸引力。此外，这些工具还对全球急性呼吸窘迫综合征设备市场的各个细分市场进行了全面评估。急性呼吸窘迫综合征设备行业的增长和趋势为本研究提供了整体方法。

市场细分：

急性呼吸窘迫综合征设备市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按类型

  • 治疗设备（机械呼吸机、PAP、其他）
  • 诊断和监测设备

按最终用户

  • 医院
  • 专科中心
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区急性呼吸窘迫综合征设备市场的当前和未来需求。此外，报告还重点分析了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。急性呼吸窘迫综合征设备市场的主要参与者包括koninklijke Plilips N.V、Medtronic、Fisher & Paykel Healthcare Limited、Dragerwerk AG & Co.KGaA, Smiths Medical (ICU Medical, Inc.), Hamilton Medical, GE Healthcare, ResMed, Getinge AB, Other.本节包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品发布和其他发展。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：急性呼吸窘迫综合征设备-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：COVID-19疫情影响分析

第六章：全球急性呼吸窘迫综合征设备市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 治疗设备（机械呼吸机、PAP、其他）
  • 诊断和监测设备

第七章 ：全球急性呼吸窘迫综合征设备市场分析：按终端用户分类

  • 终端用户概述
  • 历史和预测数据
  • 按终端用户分析
  • 医院
  • 专科中心
  • 其他

第8章：全球急性呼吸窘迫综合征设备市场分析：按地区划分

  • 地区前景
  • 产品介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美地区销售分析
    • 北美地区各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲各细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章 : 急性呼吸窘迫综合征设备企业竞争格局

  • 急性呼吸窘迫综合征设备市场竞争格局
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第10章 : 公司概况

  • 顶级公司市场份额分析
  • 市场集中度
  • koninklijke Plilips N.V
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Medtronic
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Fisher & Paykel Healthcare Limited.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Dragerwerk AG & Co. KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Smiths Medical (ICU Medical Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Hamilton Medical
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GE Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • ResMed
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Getinge AB
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Other
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

Product Code: VMR112110668

The global demand for Acute Respiratory Distress Syndrome Devices Market is presumed to reach the market size of nearly USD 669.86 MN by 2030 from USD 314.32 MN in 2022 with a CAGR of 9.92% under the study period 2023 - 2030.

Acute Respiratory Distress Syndrome (ARDS) devices refer to medical devices and equipment used to provide respiratory support to patients suffering from ARDS. ARDS is a severe respiratory condition that can occur in response to various medical conditions, such as pneumonia, sepsis, trauma, or inhalation injury. It is characterized by inflammation in the lungs that can lead to fluid accumulation and difficulty breathing. ARDS devices are used to help patients with ARDS breathe more easily and effectively. Some examples of ARDS devices include mechanical ventilators, extracorporeal membrane oxygenation (ECMO) machines, and high-flow nasal cannula systems. ARDS devices are critical in the treatment of patients with ARDS, as the condition can be life-threatening. These devices can help improve oxygenation and reduce the workload on the lungs, allowing the patient to recover from the underlying condition that led to ARDS.

Market Dynamics:

The incidence of ARDS is increasing due to factors such as ageing populations, increasing rates of chronic diseases, and higher rates of sepsis and pneumonia leading to growing need for ARDS devices to provide respiratory support for patients with this condition. Technological advancements in respiratory support devices, such as mechanical ventilators and ECMO machines, have improved the efficiency and effectiveness of these devices, driving the growth of the ARDS devices market. For example, new ventilation modes, such as volume-controlled ventilation and pressure-controlled ventilation, can provide more precise control of respiratory support. The geriatric population is growing globally, leading to an increased demand for ARDS devices as older adults are more susceptible to respiratory conditions such as ARDS. Additionally, the geriatric population often has other comorbidities that may require the use of ARDS devices. Governments around the world are investing in medical research, clinical trials and initiatives aimed at improving outcomes for patients with ARDS. The COVID-19 pandemic has led to a ARDS devices surge in demand for, particularly mechanical ventilators, as severe cases of COVID-19 can lead to ARDS.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute respiratory distress syndrome devices. The growth and trends of acute respiratory distress syndrome devices industry provide a holistic approach to this study.

Market Segmentation:

This section of the acute respiratory distress syndrome devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Therapeutic Devices (Mechanical Ventilators, PAP, Others)
  • Diagnostic & Monitoring Devices

By End User

  • Hospitals
  • Specialty Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Respiratory Distress Syndrome Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute respiratory distress syndrome devices market include koninklijke Plilips N.V, Medtronic, Fisher & Paykel Healthcare Limited., Dragerwerk AG & Co. KGaA, Smiths Medical (ICU Medical, Inc.), Hamilton Medical, GE Healthcare, ResMed, Getinge AB, Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Therapeutic Devices (Mechanical Ventilators, PAP, Others) Historic and Forecast Sales by Regions
  • 6.5 Diagnostic & Monitoring Devices Historic and Forecast Sales by Regions

7 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY END USER

  • 7.1 Overview by End User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Specialty Centers Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES COMPANIES

  • 9.1. Acute Respiratory Distress Syndrome Devices Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. koninklijke Plilips N.V
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Medtronic
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Fisher & Paykel Healthcare Limited.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Dragerwerk AG & Co. KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Smiths Medical (ICU Medical Inc.)
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Hamilton Medical
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. GE Healthcare
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. ResMed
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Getinge AB
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Other
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Therapeutic Devices (Mechanical Ventilators, PAP, Others) Market Sales by Geography (USD MN)
  • Diagnostic & Monitoring Devices Market Sales by Geography (USD MN)
  • Analysis Market by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Acute Respiratory Distress Syndrome Devices Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Acute Respiratory Distress Syndrome Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Acute Respiratory Distress Syndrome Devices Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Therapeutic Devices (Mechanical Ventilators, PAP, Others) Market Sales by Geography (USD MN)
  • Diagnostic & Monitoring Devices Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.